CURO Group Holdings Corp.
CUROQ
$0.041
$0.0012.50%
| Weiss Ratings | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2.09 | |||
| Price History | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.75 | |||
| 52-Week Low Price | $0.02 | |||
| 52-Week Low Price (Date) | Jun 13, 2024 | |||
| 52-Week High Price (Date) | Aug 01, 2023 | |||
| Valuation | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | -- | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -10.05 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.01 | |||
| Price/Book (Q) | 0.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | -- | |||
| Dividends and Shares | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 41.27M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.11 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -0.09% | |||
| Dividend Per Share (Most Recent) | $0.11 | |||
| Company Info | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 312 470 2000 | |||
| Address | 200 W Hubbard Street Chicago, IL 60654 | |||
| Website | www.curo.com | |||
| Country | United States | |||
| Year Founded | 1997 | |||
| Profitability | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -43.53% | |||
| Profit Margin | -157.43% | |||
| Management Effectiveness | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | 260.19M | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 215.67M | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -409.63M | |||
| Net Income Avl. to Common (TTM) | -409.63M | |||
| Total Revenue Growth (Q YOY) | -24.24% | |||
| Earnings Growth (Q YOY) | -259.17% | |||
| EPS Diluted (TTM) | -10.05 | |||
| EPS Diluted Growth (Q YOY) | -501.03% | |||
| Balance Sheet | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 82.55M | |||
| Cash Per Share (Q) | $2.00 | |||
| Total Current Assets (Q) | 1.31B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -398.02M | |||
| Current Ratio (Q) | 15.545 | |||
| Book Value Per Share (Q) | -$9.64 | |||
| Total Assets (Q) | 1.78B | |||
| Total Current Liabilities (Q) | 84.30M | |||
| Total Debt (Q) | 2.08B | |||
| Total Liabilities (Q) | 2.17B | |||
| Total Common Equity (Q) | -398.02M | |||
| Cash Flow | CUROQ - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -245.28M | |||
| Cash from Financing (TTM) | 221.87M | |||
| Net Change in Cash (TTM) | 32.31M | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | 50.68M | |||
